Legend Biotech (LEGN) Non-Current Deffered Revenue: 2019-2025
Historic Non-Current Deffered Revenue for Legend Biotech (LEGN) over the last 5 years, with Jun 2025 value amounting to $6.9 million.
- Legend Biotech's Non-Current Deffered Revenue rose 4.76% to $6.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.9 million, marking a year-over-year increase of 4.76%. This contributed to the annual value of $48.0 million for FY2023, which is N/A change from last year.
- According to the latest figures from Q2 2025, Legend Biotech's Non-Current Deffered Revenue is $6.9 million, which was up 13.68% from $6.1 million recorded in Q1 2025.
- Legend Biotech's Non-Current Deffered Revenue's 5-year high stood at $48.0 million during Q4 2023, with a 5-year trough of -$242.6 million in Q4 2021.
- Over the past 3 years, Legend Biotech's median Non-Current Deffered Revenue value was $6.8 million (recorded in 2023), while the average stood at $11.3 million.
- Per our database at Business Quant, Legend Biotech's Non-Current Deffered Revenue tumbled by 188.19% in 2021 and then skyrocketed by 95,121.15% in 2022.
- Quarterly analysis of 5 years shows Legend Biotech's Non-Current Deffered Revenue stood at -$242.6 million in 2021, then plummeted by 44.33% to $1.1 million in 2022, then soared by 534.52% to $48.0 million in 2023, then dropped by 3.19% to $6.5 million in 2024, then increased by 4.76% to $6.9 million in 2025.
- Its Non-Current Deffered Revenue stands at $6.9 million for Q2 2025, versus $6.1 million for Q1 2025 and $6.5 million for Q3 2024.